A new study identifies fibroblast growth factor 13 (FGF13) as a critical protector of neurons in the inner ear, offering potential therapeutic angles for combating age-associated hearing decline. This discovery adds to growing evidence on molecular mechanisms underlying auditory deterioration in the aging population.